- Home
- XNCR vs MAX Comparison
XNCR vs MAX Comparison
Compare XNCR & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | MAX |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 722.8M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | XNCR | MAX |
|---|---|---|
| Price | $10.82 | $8.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $22.78 | $17.00 |
| AVG Volume (30 Days) | ★ 683.5K | 615.0K |
| Earning Date | 02-26-2026 | 02-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $150,132,000.00 | ★ $1,123,093,000.00 |
| Revenue This Year | $18.68 | $30.80 |
| Revenue Next Year | N/A | $8.49 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 38.16 | ★ 64.86 |
| 52 Week Low | $6.92 | $7.33 |
| 52 Week High | $18.69 | $13.92 |
Technical Indicators
Market Signals| Indicator | XNCR | MAX |
|---|---|---|
| Relative Strength Index (RSI) | 26.26 | 13.12 |
| Support Level | $11.82 | $10.03 |
| Resistance Level | $12.44 | $10.46 |
| Average True Range (ATR) | 0.72 | 0.46 |
| MACD | -0.12 | -0.21 |
| Stochastic Oscillator | 1.34 | 0.63 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.